Brief: Oncozenge Signs Non-Binding Deal With Molteni Farmaceutici

Oncozenge AB

14/01/2025 06:59

Jan 14(Reuters) - Oncozenge AB  ONCOZ.ST :
    * SAID ON MONDAY CO SIGNED NON-BINDING DEAL WITH MOLTENI
FARMACEUTICI FOR BUPIZENGE™ COMMERCIALIZATION IN EUROPE
    * DEAL WILL INCLUDE ROYALTIES OF 15% TO ONCOZENGE ON
BUPIZENGE
SALES 
    * DEAL INCLUDES MILESTONE PAYMENTS TOTALING EUR 2.3 MILLION,
TIED
TO SIGNING, PHASE III COMPLETION, FIRST SALE, AND SALES
MILESTONES
    * MOLTENI OPEN TO DISCUSS ADDITIONAL MILESTONE PAYMENTS FOR
CUMULATIVE NET SALES OF EUR 30 MLN AND EUR 40 MLN

       
 Source text for Workspace:  urn:newsml:reuters.com:*:nWkr4Bz0Fp
 Further company coverage:  ONCOZ.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))